ACUVUE® NEWS—A daily disposable contact lens for the presbyopic astigmat

From the family of ACUVUE® OASYS MAX 1-Day comes ACUVUE® OASYS MAX 1‑Day MULTIFOCAL for ASTIGMATISM.

Featuring four proprietary technologies in a single lens, it delivers clear vision at all distances and in all lighting conditions, plus all-day comfort and exceptional stability.² Plus, it’s designed for patients with up to 1.75D cyl.

PUPIL OPTIMIZED Design tailors 100% of the optical designs to pupil size variation across age and refraction.*³

BLINK STABILIZED® Design features four stability zones with vertical and horizontal symmetry so they are more resistant to gravity and realign naturally with every blink to provide clear and stable vision.⁴

TearStable™ Technology optimizes PVP (a tear-like wetting agent) distribution throughout the lens and at the surface, reducing evaporation nearly two times more than other leading competitors and prolonging tear-film stability.^{^^5-7}

OptiBlue™ Light Filter provides the highest level of blue-violet light filtering^.†#5,7 The combination of OptiBlue™ Filter with TearStable™ Technology in the ACUVUE® MAX 1-Day Family allows the lens to reduce light scatter.^##5,6

Fit 92.3% of your presbyopic patients’ eyes with the MAX MULTIFOCAL Family⁸ – even those with astigmatism!

Authors: Meredith Bishop OD MS FAAO, Senior Manager Global Professional Education and Development at Johnson & Johnson Vision Care, Inc. David Ruston BSc FCOptom DipCLP FAAO, Director Global Professional Education and Development at
Johnson & Johnson Medical Ltd.

This Post is sponsored by Johnson & Johnson.

* Compared to Competitor’s design, technology optimized for both the parameter of refractive error and ADD power.

†Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for more information.
^^Versus Dailies Total1®, MyDay® and Ultra® One Day, also significantly lower versus ACUVUE® OASYS 1 Day.
#Versus publicly available information for standard daily use contact lenses as of December 2023.
##Versus ACUVUE® OASYS 1-Day.

References

1. JJV Data on File 2024, First and Only Daily Disposable Multifocal Toric Contact Lens in US.
2. JJV Data on File 2024. Subjective Standalone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses for ASTIGMATISM.
3. JJV Data on File 2022. ACUVUE® PUPIL OPTIMIZED DESIGN TECHNOLOGY: JJVC contact lenses, design features, and associated benefits.
4. JJV Data on File 2024. ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
5. JJV Data on File 2022. TearStable™ Technology Definition.
6. JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts of ACUVUE® OASYS MAX 1-DAY Family with TearStable™ Technology.
7. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-DAY with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands.
8. JJV Data on File 2024. SKU Coverage Claims for ACUVUE® OASYS MAX 1-Day and ACUVUE® OASYS MAX 1-Day MULTIFOCAL Brand Contact Lenses.

Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-800-267-5098 or by visiting www.jnjvisionpro.com/en ca/.

The third-party trademarks used herein are the intellectual property of their respective owners.
© Johnson & Johnson and its affiliates 2025  2025PP15771